Stocktoria
OptimizeRx Corp OPRX
Nasdaq · XNAS · stock · Services-Business Services, NEC · website · IPO 2005-05-18
OptimizeRx Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 67.3% | 64.5% | 60.0% | — | 62.4% |
| Operating margin | 10.7% | -14.9% | -36.9% | — | -19.7% |
| Net margin | 4.7% | -21.8% | -24.6% | — | -18.3% |
| FCF margin | 17.0% | 5.2% | -10.2% | — | 16.9% |
| Return on assets | 2.9% | -11.7% | -9.6% | — | -8.5% |
| Return on equity | 4.0% | -17.2% | -13.9% | — | -9.1% |
| Debt / equity | 0.20× | 0.29× | 0.30× | — | — |
| Current ratio | 3.04 | 2.89 | 3.04 | 15.44 | 11.74 |
| Revenue growth | 18.8% | 28.8% | — | — | 1.9% |
Source: SEC EDGAR filings · CIK 0001448431 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.